219 related articles for article (PubMed ID: 27836794)
21. Economic burden of nosocomial infections caused by vancomycin-resistant enterococci.
Puchter L; Chaberny IF; Schwab F; Vonberg RP; Bange FC; Ebadi E
Antimicrob Resist Infect Control; 2018; 7():1. PubMed ID: 29312658
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of vancomycin-resistant Enterococcus cases at a tertiary level hospital in Izmir, Turkey].
Atalay S; Ece G; Samlıoğlu P; Maraş G; Köse I; Köse S
Mikrobiyol Bul; 2012 Oct; 46(4):553-9. PubMed ID: 23188569
[TBL] [Abstract][Full Text] [Related]
23. Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients.
Nolan SM; Gerber JS; Zaoutis T; Prasad P; Rettig S; Gross K; McGowan KL; Reilly AF; Coffin SE
Infect Control Hosp Epidemiol; 2009 Apr; 30(4):338-45. PubMed ID: 19239375
[TBL] [Abstract][Full Text] [Related]
24. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
[TBL] [Abstract][Full Text] [Related]
25. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
[TBL] [Abstract][Full Text] [Related]
26. Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection.
Dahms RA; Johnson EM; Statz CL; Lee JT; Dunn DL; Beilman GJ
Arch Surg; 1998 Dec; 133(12):1343-6. PubMed ID: 9865653
[TBL] [Abstract][Full Text] [Related]
27. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
28. Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review.
de Bruin MA; Riley LW
BMC Infect Dis; 2007 Apr; 7():24. PubMed ID: 17425800
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital.
Tucci V; Haran MA; Isenberg HD
Am J Infect Control; 1997 Oct; 25(5):371-6. PubMed ID: 9343618
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
31. Determination of risk factors associated with isolation of linezolid-resistant strains of vancomycin-resistant Enterococcus.
Pogue JM; Paterson DL; Pasculle AW; Potoski BA
Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1382-8. PubMed ID: 17994519
[TBL] [Abstract][Full Text] [Related]
32. Vancomycin-resistant enterococcus in end-stage renal disease.
Brady JP; Snyder JW; Hasbargen JA
Am J Kidney Dis; 1998 Sep; 32(3):415-8. PubMed ID: 9740157
[TBL] [Abstract][Full Text] [Related]
33. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE;
Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484
[TBL] [Abstract][Full Text] [Related]
34. Rising Vancomycin-Resistant Enterococcus Infections in Hospitalized Children in the United States.
Adams DJ; Eberly MD; Goudie A; Nylund CM
Hosp Pediatr; 2016 Jul; 6(7):404-11. PubMed ID: 27250774
[TBL] [Abstract][Full Text] [Related]
35. Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin.
Shin JW; Yong D; Kim MS; Chang KH; Lee K; Kim JM; Chong Y
J Infect Chemother; 2003 Mar; 9(1):62-7; discussion 104-5. PubMed ID: 12673410
[TBL] [Abstract][Full Text] [Related]
36. The occurrence of vancomycin-resistant enterococci in hematological patients in relation to antibiotic use.
Kolar M; Vagnerova I; Latal T; Urbanek K; Typovska H; Hubacek J; Papajik T; Raida L; Faber E
New Microbiol; 2002 Apr; 25(2):205-12. PubMed ID: 12019727
[TBL] [Abstract][Full Text] [Related]
37. The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.
Carmeli Y; Samore MH; Huskins C
Arch Intern Med; 1999 Nov; 159(20):2461-8. PubMed ID: 10665895
[TBL] [Abstract][Full Text] [Related]
38. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
Lee SC; Lee CW; Shih TC; See LC; Chu CM; Liu YC
J Microbiol Immunol Infect; 2016 Oct; 49(5):749-759. PubMed ID: 27156242
[TBL] [Abstract][Full Text] [Related]
39. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
[TBL] [Abstract][Full Text] [Related]
40. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
Olivier CN; Blake RK; Steed LL; Salgado CD
Infect Control Hosp Epidemiol; 2008 May; 29(5):404-9. PubMed ID: 18419361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
